FDA orphan products development
Executive Summary
Former Center for Biologics Evaluation & Research Office of Cellular, Tissue & Gene Therapies Acting Director Phil Noguchi, MD, will leave FDA at the end of August. Noguchi has held the position of medical officer within the Office of Orphan Products Development since May (1"The Pink Sheet" May 17, 2004, In Brief)...